Patent assignee · AU · COMPANY

Prana Biotechnology Limited

19Patents
13Active
19Granted
43Portfolio score

Filing activity: Jul 21, 2000 → Jun 24, 2020 · 5 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8084459B2 Substituted quinazolinones for treating neurological conditions Chemistry; Metallurgy 36 Expired
US7619091B2 8-hydroxy quinoline derivatives Emerging Cross-Sectional Technologies 10 Expired
US8163760B2 Use of pyridopyrimidine compounds in the treatment of gliomas Human Necessities 3 Active
US8318171B2 Neurotoxic oligomers Human Necessities 3 Active
US8389506B2 Compounds for therapy and diagnosis Chemistry; Metallurgy 2 Active
US8889695B2 Quinazolinone compounds Emerging Cross-Sectional Technologies 2 Active
US8975278B2 8-hydroxy quinoline derivatives Emerging Cross-Sectional Technologies 2 Active
US7692011B2 8-hydroxy and 8-mercapto quinazolinones Chemistry; Metallurgy 2 Active
US7618634B2 Neurotoxic oligomers Human Necessities 1 Expired
US9169211B2 8-hydroxy quinoline derivatives Emerging Cross-Sectional Technologies 0 Active
US9145375B2 Quinazolinone compounds Emerging Cross-Sectional Technologies 0 Active
US7629354B2 Use of phanquinone for the treatment of Alzheimer's disease Human Necessities 0 Expired
US9163018B2 Method of treatment of age-related macular degeneration (AMD) Human Necessities 0 Active
US10287285B2 4H-pyrido[1,2-A]pyrimidin-4-one compounds Chemistry; Metallurgy 0 Active
US9302993B2 8-hydroxy quinoline derivatives Emerging Cross-Sectional Technologies 0 Active
US11008319B2 4H-pyrido[1,2-a]pyrimidin-4-one compounds Chemistry; Metallurgy 0 Active
US10738050B2 4H-pyrido[1,2-A]pyrimidin-4-one compounds Chemistry; Metallurgy 0 Active
US7704987B1 β-amyloid peptide inhibitors Human Necessities 0 Expired
US7030136B2 Use of phanquinone for the treatment or prevention of memory impairment Human Necessities 0 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.